Following their discussion on axicabtagene ciloleucel and lisocabtagene maraleucel, panelists reflect on the real-world use of CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.
complex walk or cycle, it is a former complex on that, the consultation and away you consult with patient because and away you consult with patient because a and away you consult with patient because a patient and doctor relationship can be a conversation of looking relationship can be a conversation of looking up all the holistic factors of looking up all the holistic factors. he wanted medicalised a lot of the factors. he wanted medicalised a lot of the conditions because we know there of the conditions because we know there are of the conditions because we know there are social issues attached. for example a headache or the pain, it might for example a headache or the pain, it might not for example a headache or the pain, it might notjust be that, there might it might notjust be that, there might be it might notjust be that, there might be social factors, the mighty work concerns, sleep factors, we need work concerns, sleep factors, we need to work concerns,
Go to
Brief Summary:
The pandemic caused by the novel coronavirus SARS-CoV-2 has resulted in substantial global morbidity and mortality including in Oklahoma and caused unprecedented interruptions in nearly all aspects of our lives. The population of the state of Oklahoma is at particular risk to SARS-CoV-2 due to its large rural population, strained healthcare system, and poor overall health. The Community-Engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations (CATCH-UP) program will involve both practice-based and community-based approaches to maximize the reach of the RADx-UP consortium, broaden the potential perspectives that could be captured, and compare the effectiveness of strategies. The interventions will be pragmatic to allow CATCH-UP to respond to changing attitudes, barriers, and environments as the pandemic progresses as well as expected technology developments to produce more effective viral testing that can provide rapid re